Major depressive disorder (MDD) is a highly prevalent mental illness and leading cause of disability worldwide. While treatments exist, they are far from optimal and up to 30% of patients fail to respond. There is an urgent need to identify factors that may enhance treatment response in MDD. Targeting inflammation has been proposed as a …
The novel combination drug dextromethorphan-bupropion (Auvelity) was recently approved by the FDA as an oral antidepressant that works rapidly to treat major depressive disorder in adults. This new medication represents an exciting development for depression treatment. Here are some key facts about this drug: Works significantly faster than standard antidepressants, showing efficacy in as little …
Depression is one of the most common and burdensome mental health disorders globally, affecting over 300 million people. While antidepressant medications can help many patients recover, up to a third do not respond adequately to first-line treatments. This has led doctors to try combining medications in the hopes of better outcomes. One such combination that …
Bipolar disorder is a mental illness characterized by extreme mood swings between depression and mania. While antidepressants are commonly prescribed to treat the depressive symptoms, they can also trigger manic episodes in some patients. New research suggests having a certain gene may increase this risk. Key Facts: Antidepressants can cause manic episodes, called treatment emergent …
Researchers are gaining exciting new insights into how the drug ketamine can rapidly treat symptoms of depression, including in people who don’t respond to other antidepressants. Key facts about ketamine for depression: Ketamine is an FDA-approved anesthetic that has been found to quickly improve mood in depressed patients, including those with treatment-resistant depression. It works …
A new study published in the journal Mædica – a Journal of Clinical Medicine compared the antidepressant effects of modafinil versus citalopram for treating major depressive disorder (MDD). The medications were equally effective at reducing depressive symptoms over a 6-week treatment period. Key facts: 30 patients with MDD were treated with either modafinil or citalopram …
A new brain imaging study provides insight into how antidepressants like selective serotonin reuptake inhibitors (SSRIs) may bring about symptom improvement in adolescents with major depressive disorder. The findings suggest that changes in a brain region involved in cognitive control may serve as markers of treatment response. Key Facts: Researchers used MRI scans to examine …
A new study reveals that widely prescribed antidepressants may cause persistent erectile dysfunction in a small but significant number of male patients. Key Facts: The study found that serotonergic antidepressants like SSRIs and SNRIs triple the risk of erectile dysfunction (ED) compared to non-users. After stopping the antidepressants, 0.46% of patients (1 out of every …
A study finds that antidepressant treatment reduces empathy – but depression itself doesn’t impact empathy. Key Facts: People with untreated depression showed normal empathy and brain responses. After 3 months of antidepressant treatment, they showed reduced empathy and brain responses. The more their depressive symptoms improved, the more their empathy decreased. Antidepressants specifically reduced emotional …
